Nuvo Research Inc. is a specialty pharmaceutical company with a diverse portfolio of topical and immunology products. The Company operates two business units: the Topical Products and Technology (TPT) Group and the Immunology Group. The TPT Group has four commercial products, a pipeline of topical and transdermal proprietary drug delivery (TTDD) products focusing on pain and dermatology and four drug delivery platforms that support the development of patented formulations that deliver actives into or through the skin. The TTDD platforms are multiplexed molecular penetration enhancers, Controlled Heat-Assisted Drug Delivery, Peel and DuraPeel. The TPT Group�s four products include Pennsaid, Pennsaid 2%, the heated lidocaine/tetracaine patch and Pliaglis. The Immunology Group has two commercial products, which include a development program for the treatment of allergic rhinitis and an immune system modulation platform to support treatments for a range of immune system related disorders.